Advertisement

Topics

Companies Related to "ORYZON present preclinical data 2001 Neuroscience 2017 meeting" [Most Relevant Company Matches] RSS

22:35 EST 20th November 2018 | BioPortfolio

Here are the most relevant search results for "ORYZON present preclinical data 2001 Neuroscience 2017 meeting" found in our extensive corporate database of over 50,000 company records.

Showing "ORYZON present preclinical data 2001 Neuroscience 2017 meeting" Companies 1–25 of 4,100+

Extremely Relevant

Oryzon Genomics

Oryzon genomics is a functional genomics company based in Barcelona, Spain. It was launched in 2001 as a spin-off of the Spanish National Research Council (CSIC) and the University of Barcelona, and has an international staff of 30 highly qualified scientists.


Relevant

Society for Neuroscience

The Society for Neuroscience is a nonprofit membership organization of basic scientists and physicians who study the brain and nervous system. Recognizing the field's tremendous potential, the Society was formed in 1969. It has grown from 500 members to more than 37,500 and is the world's largest organization of scientists devoted to the study of the brain.The Society's primary goal is to promote ...

Neurosciences Victoria Ltd

NSV® was formed in 2001 to facilitate technology transfer and inward investment into the vibrant and expanding Melbourne neuroscience cluster.NSV provides a "one-stop-shop" for current and potential investors in Australian neuroscience R & D. Through the creation of relationships with biotechnology and pharmaceutical companies, NSV Ltd aims to facilitate new product development for the diagnosis,...


Cohesity

Cohesity makes your data work for you by consolidating secondary storage silos onto a hyperconverged, web-scale data platform that spans both private and public clouds. Enterprise customers begin by radically streamlining their backup and data protection, then converge file and object services, test/dev instances, and analytic functions to provide a global...

MIXiii BIOMED

MIXiii BIOMED is Israel’s leading international life science conference and exhibition, to take place on May 23-25, 2017 at the David InterContinental Hotel in Tel Aviv. For the 16th consecutive year, MIXiii BIOMED is the largest meeting place for healthcare professionals from Israel with international colleagues and partners. As such, this world-c...

Trophogen, Inc.

Trophogen, Inc. is a U.S.-based biotechnology company founded in 2001 with Series A funding from Toucan Capital, in late stage preclinical focusing on development of human and bovine high affinity glycoprotein hormone and related growth factor superagonist analogs which are long-acting, more potent and efficacious, for human infertility, animal superovulat...

In Vitro Technologies

About Celsis In Vitro Technologies Increasing discovery. Advancing development. Leading provider of In Vitro and ADME-Tox Products. Celsis In Vitro Technologies (IVT) provides high quality, value-added in vitro products and services. We can immediately add value to your drug discovery and preclinical development program by providing large lot sizes and data sets of hepatocytes, other cell types, ...

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic can...

Neurosciences Victoria Limited

Our MissionNSV is dedicated to the continued development of the world-class neuroscience biocluster in Melbourne, Australia through a program of strategic investment in the gap between academic discovery research and commercial development.By providing focus and direction for neuroscience research and through the creation and development of strong industry partnerships, NSV provides a unique and e...

bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting

Algos Preclinical Services

Founded as Algos Therapeutics, Inc. in 2003, the company recently changed its corporate identity to Algos Preclinical Services to reflect its new strategic market positioning as a US-based preclinical, in vivo CRO that provides contract research services to pharmaceutical, biotech and medical device markets. Algos Preclinical supports the development of its customers' products from its facilities ...

Vivior

Vivior is a Swiss digital health start-up founded in 2017 by a group of experienced eye care professionals. The company develops a novel wearable device to objectively measure patient’s behavioral data prior to cataract and refractive eye surgeries. The device collects daily activity data from patients, processes these data in the cloud and analyses p...

Vivior AG

Vivior is a Swiss digital health start-up founded in 2017 by a group of experienced eye care professionals. The company develops a novel wearable device to objectively measure patient’s behavioral data prior to cataract and refractive eye surgeries. The device collects daily activity data from patients, processes these data in the cloud and analyses p...

External Pharma Inc

External Pharma, Inc. provides preclinical drug discovery and development support to pharmaceutical and biotech companies as fee for service or in collaboration with a partner. Our main focus is to evaluate drug candidates and targets for neurological and psychiatric indications. External Pharma represents the next generation of CROs - highly experienced drug development scientists working in a st...

Japan Chemical e-data Corporation

Japan Chemical e-data Corporation was established in December 2001. We started "Chemical e-data Search" in January, 2002. It will be utilized as a portal site on sale, on purchase, and on research and development of chemical products. And it aims at connecting a chemical product or manufacture technology and equipment, with any company information.

Society for General Microbiology,

The Society for General Microbiology was formally inaugurated on 16 February 1945, at a meeting of Original Members in London. Sir Alexander Fleming was elected as the first President. SGM had its origins in the (then) Society of Agricultural Bacteriologists: a number of members of that society had wished to see a broadening of its interests and scope beyond agriculture, to embrace virology, medic...

Genolyze

Genolyze is the leading Bioinformatics service company in Northern Europe. Genolyze specialises in applying cutting-edge, innovative statistical methods to the analysis of data from DNA Microarrays or other high throughput screening experiments for the pharmaceutical, biotechnology and nutraceutical industries, the data analysis also meeting the scientific requirements. By increasing the efficienc...

The Hub, LLC

The Hub is the foremost destination for off-site corporate meetings and events, offering comfortable, stylish, convenient, private and reasonably priced meeting space, top-level service and exclusive catering by STARR Events. The company also offers offsite meeting management around the world, as well as facilities management of public or private meeting centers. Built upon a foundation of corpora...

NAM Asia Hong Kong Co., Ltd.

CEO Teppei Nakano graduated from Keio University School of Medicine in 2017. We have been adopting IPA unexplored projects by the Ministry of Economy, Trade and Industry, which represent a large number of representatives of IT companies representing Japan, twice in 2016 and 2017, independent businesses that have been adopted by unexplored This is the NAM p...

NuMedii, Inc.

NuMedii discovers and de-risks effective new drugs by translating its predictive Big Data technology into therapies with a higher probability of therapeutic success.  The company’s Big Data technology, originally developed at Stanford and licensed exclusively to NuMedii, consists of billions of data points of ever-increasing amounts of comprehensive ...

Collaborative Drug Discovery, Inc.

Collaborative Drug Discovery, Inc. (CDD) -- http://www.collaborativedrug.com -- provides web-based software that organizes preclinical research data to help scientists advance new drug candidates more effectively. The CDD database enables scientists to "archive, mine, and collaborate"(R) around preclinical chemical and biological drug discovery data through a web-based interface. The software ...

Cambridge NeuroScience Incorporated

Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the nervous system. Cambridge NeuroScience is focused in two areas of research and development: (i) ion-channel blockers to prevent or treat brain damage resulting from stroke and other forms of brain isc...

Scottsdale Center for the Advancement of Neuroscience

Neuroscience advancement creates new opportunities, and new challenges. Perhaps the greatest challenge of all is to develop superior “Centers of Expertise” that bridge the gap between information and application. Founded in 2000, The Scottsdale Center for the Advancement of Neuroscience (S.C.A.N.) serves to integrate the comprehensive mix of technical expertise and industry knowledge into expe...

Bio-Boston Contract laboratories

Preclinical contract services R&D, HPLC, Peptide Synthesis, Purification, ELISA, Chemiluminescent assays, bioassays, analytical chemistry, cell culture, tissue culture, Biochemistry, synthesis, formulation support, Neuroscience, bioanalytical, methods development, LAL Endotoxin testing, sequencing, Molecular Biology, Cell Biology, Cell based Assays, Immunochemistry, chemical analysies, biochemical...

EmSense

EmSense is a leading-edge neuroscience company that applies advances in EEG and other neurometrics to provide clients with deep and reliable understanding of consumer emotions and cognitive engagement responses to marketing stimuli. The company's quantitative metrics reveal new insights for creating and optimizing advertising, concepts, packaging, products, media content, online marketing, and the...


More From BioPortfolio on "ORYZON present preclinical data 2001 Neuroscience 2017 meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks